← back to search

Barish H. Edil

University of Oklahoma Health Sciences Center · US
Area of research
Oncology · Surgery
Research interest
Research interests include Pancreatic and Hepatic Oncology Research, Pancreatitis Pathology and Treatment, Neuroendocrine Tumor Research Advances, and Cholangiocarcinoma and Gallbladder Cancer Studies.
h-index
69
citations
17,561
works
274
NIH funding
primary concept
email

Recent publications

The impact of neoadjuvant therapy in patients with left-sided resectable pancreatic cancer: an international multicenter study
Annals of Oncology 2025cited by 11position: middledoi
Anti-IL-8 antibody activates myeloid cells and potentiates the anti-tumor activity of anti-PD-1 antibody in the humanized pancreatic cancer murine model
Cancer Letters 2022cited by 30position: middledoi
New staging classification for pancreatic neuroendocrine neoplasms combining TNM stage and WHO grade classification [ ]
Cancer Letters 2021cited by 8position: middledoi
Prognostic validity of the American joint committee on cancer eighth edition staging system for well-differentiated pancreatic neuroendocrine tumors
HPB 2021cited by 5position: middledoi
RETRACTED: Actively Targeted Nanodelivery of Echinomycin Induces Autophagy-Mediated Death in Chemoresistant Pancreatic Cancer In Vivo
Cancers 2020cited by 18position: middledoi
Prognostic Validity of the American Joint Committee on Cancer Eighth Edition Staging System for Well-Differentiated Pancreatic Neuroendocrine Tumors: A Retrospective Multinational Multicenter Study
Research Square 2020cited by 0position: middledoi
The Miami International Evidence-based Guidelines on Minimally Invasive Pancreas Resection
Annals of Surgery 2019cited by 476position: middledoi
A multimodality test to guide the management of patients with a pancreatic cyst
Science Translational Medicine 2019cited by 205position: middledoi
ZIP4 Promotes Muscle Wasting and Cachexia in Mice With Orthotopic Pancreatic Tumors by Stimulating RAB27B-Regulated Release of Extracellular Vesicles From Cancer Cells
Gastroenterology 2018cited by 131position: middledoi
CD28H expression identifies resident memory CD8 + T cells with less cytotoxicity in human peripheral tissues and cancers
OncoImmunology 2018cited by 33position: middledoi
NCCN Guidelines Insights: Older Adult Oncology, Version 2.2016
Journal of the National Comprehensive Cancer Network 2016cited by 122position: middledoi
A Combination of Molecular Markers and Clinical Features Improve the Classification of Pancreatic Cysts
Gastroenterology 2015cited by 456position: middledoi
Suboptimal accuracy of carcinoembryonic antigen in differentiation of mucinous and nonmucinous pancreatic cysts: results of a large multicenter study
Gastrointestinal Endoscopy 2015cited by 90position: middledoi
PD-1/PD-L1 Blockade Together With Vaccine Therapy Facilitates Effector T-Cell Infiltration Into Pancreatic Tumors
Journal of Immunotherapy 2014cited by 394position: middledoi
A Preclinical Murine Model of Hepatic Metastases
Journal of Visualized Experiments 2014cited by 118position: middledoi
Grading of Well-differentiated Pancreatic Neuroendocrine Tumors Is Improved by the Inclusion of Both Ki67 Proliferative Index and Mitotic Rate
The American Journal of Surgical Pathology 2013cited by 175position: middledoi
A Single Institution's 26-Year Experience With Nonfunctional Pancreatic Neuroendocrine Tumors
Annals of Surgery 2013cited by 144position: lastdoi
Impact of Sarcopenia on Outcomes Following Resection of Pancreatic Adenocarcinoma
Journal of Gastrointestinal Surgery 2012cited by 549position: middledoi
Small Cell and Large Cell Neuroendocrine Carcinomas of the Pancreas are Genetically Similar and Distinct From Well-differentiated Pancreatic Neuroendocrine Tumors
The American Journal of Surgical Pathology 2012cited by 538position: middledoi
Laparoscopic Distal Pancreatectomy Is Associated With Significantly Less Overall Morbidity Compared to the Open Technique
Annals of Surgery 2012cited by 506position: middledoi
Patient Readmission and Mortality after Colorectal Surgery for Colon Cancer: Impact of Length of Stay Relative to Other Clinical Factors
Journal of the American College of Surgeons 2012cited by 271position: middledoi
Loss of ATRX or DAXX expression and concomitant acquisition of the alternative lengthening of telomeres phenotype are late events in a small subset of MEN-1 syndrome pancreatic neuroendocrine tumors
Modern Pathology 2012cited by 177position: middledoi
Cystic Pancreatic Neuroendocrine Tumors
The American Journal of Surgical Pathology 2012cited by 134position: lastdoi
Well-differentiated pancreatic neuroendocrine tumors: from genetics to therapy
Nature Reviews Gastroenterology & Hepatology 2012cited by 125position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Richard D. Schulick · University of Colorado Anschutz Medical Campus11 papers (2012–2018)Christopher L. Wolfgang · University Medical Center Hamburg-Eppendorf8 papers (2012–2013)Ralph H. Hruban · Occupational Cancer Research Centre6 papers (2012–2013)Lei Zheng · Fujian Medical University4 papers (2014–2022)Michael A. Choti · Banner - University Medical Center Phoenix4 papers (2012–2013)Trevor A. Ellison · New York University4 papers (2012–2013)Chanjuan Shi · Duke University Health System4 papers (2012–2013)John L. Cameron · Johns Hopkins University3 papers (2012–2013)Roeland F. de Wilde · Karolinska University Hospital3 papers (2012–2012)Kelly Olino · Yale Cancer Center3 papers (2013–2014)Toby C. Cornish · Medical College of Wisconsin2 papers (2013–2013)Martin A. Makary · United States Food and Drug Administration2 papers (2012–2012)Timothy M. Pawlik · Columbus Oncology and Hematology Associates2 papers (2012–2013)David S. Klimstra · Marmara University2 papers (2012–2013) · 2 papers (2013–2013)Laura H. Tang · Colorado Permanente Medical Group2 papers (2012–2013)Aatur D. Singhi · UPMC Hillman Cancer Center2 papers (2012–2013)Daniel A. Laheru · NYU Langone Health2 papers (2012–2014)Anirban Maitra · The University of Texas MD Anderson Cancer Center2 papers (2012–2012)Elizabeth M. Jaffee · NYU Langone Health2 papers (2014–2014)